PathMaker Neurosystems
PrivateLast Round
Grant
Jun 3, 2025
Total Funding Raised
$11.12M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PathMaker Neurosystems is a medical technology company that develops non-invasive neuromodulation devices for the treatment of serious neurological disorders such as ALS and stroke-related spasticity.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PathMaker Neurosystems Comparables
Compare PathMaker Neurosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SpineX Inc. | 88% | |
| MyndTec Inc. | 81% | |
| Solana Company | 78% |
PathMaker Neurosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 3, 2025 | ||||
| Grant | Jun 5, 2024 | ||||
| Grant | Jun 5, 2023 | ||||
| VC Round | Jan 17, 2023 | ||||
| Grant | Jun 8, 2022 | ||||
Grant | Feb 1, 2022 |
Key People
Founding team and executive leadership
PathMaker Neurosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MassVentures | Grant |
| Cullen Education and Research Fund | Grant |
| Massachusetts Life Sciences Center | Grant |
| Congressionally Directed Medical Research Programs | Grant |
| Muscular Dystrophy Association | VC Round |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 32% MoM, from 1.4K to 1.9K.
- Jun 3, 2025
$500K grant from Rhode Island Office of Energy Resources.
Recent news
Latest coverage and updates
- is_developingOct 13, 2026
PathMaker Neurosystems Inc. develops MyoRegulator
PathMaker Neurosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PathMaker Neurosystems's valuation, stock price, and market status.
Is PathMaker Neurosystems a public or private company?
PathMaker Neurosystems is a private company.
What is the current stock price of PathMaker Neurosystems?
PathMaker Neurosystems is a private company, so its shares have no public market price. Caplight tracks PathMaker Neurosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PathMaker Neurosystems worth (valuation)?
Valuation information for PathMaker Neurosystems is not publicly available.
Can I buy PathMaker Neurosystems stock?
PathMaker Neurosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PathMaker Neurosystems's last funding round?
PathMaker Neurosystems's most recent funding round was Grant on June 3, 2025.
Who are the main investors in PathMaker Neurosystems?
Key investors in PathMaker Neurosystems include MassVentures, Cullen Education and Research Fund, Massachusetts Life Sciences Center, Congressionally Directed Medical Research Programs, Muscular Dystrophy Association.
Will PathMaker Neurosystems IPO soon?
No public IPO plans have been announced for PathMaker Neurosystems.
How can I track PathMaker Neurosystems secondary market activity?
Caplight tracks bids, offers, and trades in PathMaker Neurosystems's shares on secondary markets.